Literature DB >> 3262003

"Haemostasis time", a modified bleeding time test and its comparison with the Duke and Ivy/template bleeding times. II. Application in bleeding disorders.

H Janzarik1, D Heinrich, R H Bödeker, H G Lasch.   

Abstract

"Haemostasis time" (HT), the occlusion time of a Butterfly 25 short cannula inserted into the cubital vein, is a bleeding time modification comparable to the skin bleeding times according to Duke and Ivy/Mielke. It also measures platelet function and is not influenced more than the latter tests by clotting factors. In HT, subendothelium is replaced by a standard artificial surface. The technique was investigated in patients with haemophilia A and B, von Willebrand's disease (vWD), and defects of factors VII and XI. HT was prolonged in 9/16 patients with haemophilia A/B, but did not correlate with the factor VIII:C/IX:C values. However, it reflected the different bleeding tendencies in those patients as represented by early or late onset of bleeding symptoms and occurrence of spontaneous haemarthroses. Of the vWD patients, not classified by multimeric analysis, 15/31 had prolonged Simplate II bleeding times, 14/31 prolonged HTs. Only 20/31 patients had corresponding normal or prolonged bleeding times with both techniques. HT correlated significantly with the Duke bleeding time (p = 0.011), ristocetin cofactor activity (p = 0.003) and von Willebrand factor antigen (p = 0.022), while no correlations were found between these parameters and the Simplate II method. Statistical evaluation shows, that in vWD, HT can replace the less precise Duke bleeding time but not the non-related Ivy/Simplate techniques.

Entities:  

Mesh:

Year:  1988        PMID: 3262003     DOI: 10.1007/bf00320149

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  20 in total

1.  The bleeding time as a test of hemostatic function.

Authors:  A J Quick
Journal:  Am J Clin Pathol       Date:  1975-07       Impact factor: 2.493

2.  Letter: A method for assaying von Willebrand factor (ristocetin cofactor).

Authors:  D E Macfarlane; J Stibbe; E P Kirby; M B Zucker; R A Grant; J McPherson
Journal:  Thromb Diath Haemorrh       Date:  1975-09-30

3.  THE DUKE AND IVY METHODS FOR DETERMINATION OF THE BLEEDING TIME.

Authors:  I M NILSSON; S MAGNUSSON; C BORCHGREVINK
Journal:  Thromb Diath Haemorrh       Date:  1963-11-01

4.  Aggregation of blood platelets by adenosine diphosphate and its reversal.

Authors:  G V BORN
Journal:  Nature       Date:  1962-06-09       Impact factor: 49.962

5.  [Determination of bleeding time in childhood and its clinical utilization].

Authors:  A H Sutor; M Heidmann; W Künzer
Journal:  Med Welt       Date:  1974-03-08

6.  Bleeding time after aspirin in disorders of intrinsic clotting.

Authors:  M M Kaneshiro; C H Mielke; C K Kasper; S I Rapaport
Journal:  N Engl J Med       Date:  1969-11-06       Impact factor: 91.245

7.  Von Willebrand's disease: a comparative study of diagnostic tests.

Authors:  C F Abildgaard; J V Simone; G R Honig; E N Forman; C A Johnson; R A Seeler
Journal:  J Pediatr       Date:  1968-09       Impact factor: 4.406

8.  The standardized normal Ivy bleeding time and its prolongation by aspirin.

Authors:  C H Mielke; M M Kaneshiro; I A Maher; J M Weiner; S I Rapaport
Journal:  Blood       Date:  1969-08       Impact factor: 22.113

9.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

Authors:  C B Laurell
Journal:  Anal Biochem       Date:  1966-04       Impact factor: 3.365

10.  "Haemostasis time", a modified bleeding time test and its comparison with the Duke and Ivy/template bleeding times. I. Normal values, application in thrombocytopenic patients and evaluation of heparin and aspirin effects.

Authors:  H Janzarik; S Remy; S Morell; W Pabst
Journal:  Blut       Date:  1986-06
View more
  1 in total

1.  Failure of the platelet-activating-factor antagonist WEB 2086 BS for treatment of chronic autoimmune thrombocytopenia.

Authors:  G Giers; H Janzarik; E R Kempe; C Mueller-Eckhardt
Journal:  Blut       Date:  1990-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.